US Patent Issued to Newave Pharmaceutical on Feb. 17 for "1H-pyrrolo[2,3-bpyridine derivatives as BCL-2 inhibitors for the treatment of neoplastic and autoimmune diseases" (California Inventor)

ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,552,784, issued on Feb. 17, was assigned to Newave Pharmaceutical Inc. (Pleasanton, Calif.).

"1H-pyrrolo[2,3-bpyridine derivatives as BCL-2 inhibitors for the treatment of neoplastic and autoimmune diseases" was invented by Yi Chen (Pleasanton, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to 1H-pyrrolo[2,3-b]pyridine derivatives and related compounds as BCL-2 inhibitors for treating neoplastic, autoimmune or neurodegenerative diseases. The present description discloses the synthesis and characterisation of exemplary compounds as well as pharmacological data thereof (e.g. pages 162 to 233; examples 1 to 8; table; co...